Eli Lilly and Company (LLY) 2023 AAIC Lilly Alzheimer's Disease Update Conference (Transcript)

Eli Lilly and Company (NYSE:LLY) 2023 AAIC Lilly Alzheimer’s Disease Update Conference July 17, 2023 1:00 PM ET Company Participants Lauren Zierke - Executive Director of IR Daniel Skovronsky - Chief Scientific and Medical Officer Anne White - President, Lilly Neuroscience Mark Mintun - Group Vice President of Neuroscience Research and Development; President, Avid Radiopharmaceuticals John Sims - Head of Clinical Development for Donanemab Conference Call Participants Tim Anderson - Wolfe Research Alec Stran ...